Skip to content Skip to footer
Menu Close
Close
Endocrinology

Join Type 1 Diabetes Clinical Trials Focused on Immune-Based Research and Care

Diabetes Research

Type 1 Diabetes Clinical Trials in Houston, TX

Type 1 diabetes is an autoimmune condition that prevents the body from producing enough insulin, making daily blood sugar management essential. Often diagnosed in children and young adults, the condition can affect long-term health and quality of life.

Zillan Clinical Research is conducting a Phase 1b/2a type 1 diabetes clinical trial that evaluates an investigational drug to determine whether it is safe, well-tolerated, and may help preserve insulin-producing cells in people with newly diagnosed Type 1 Diabetes. Participants will receive three IV infusions and be closely monitored throughout the study.

Check Eligibility
T1D Clinical Trials

Advancing Research for Recently Diagnosed Type 1 Diabetes

Living with type 1 diabetes can be challenging, but ongoing research brings new hope. Zillan Clinical Research is conducting autoimmune diabetes clinical trials to test a new investigational treatment in people who were recently diagnosed with Type 1 Diabetes (T1D).

During the study, eligible participants receive close medical monitoring, including safety, immune response, and pancreatic function assessments. All study-related care is provided at no cost, with the goal of improving future type 1 diabetes treatment and outcomes.

Now Enrolling

Current Status

Stage 3 Type 1 Diabetes

Condition
Partner With Us
Our Values

Why Patients Trust Us

At Zillan Clinical Research, we conduct ethical, high-quality clinical studies focused on patient safety, scientific integrity, and advancing innovative treatments for better health outcomes.

Integrity

Conducting all studies with honesty, transparency, and strict ethical standards

Patient Safety

Prioritizing participant well-being through close monitoring and care

Scientific Excellence

Following high-quality research practices and global clinical standards

Innovation

Supporting advanced research approaches that drive medical progress

Diversity & Inclusion

Ensuring studies reflect real-world patient populations

Trusted Oversight

Operating under regulated, GCP-compliant clinical research processes

FAQ

Frequently Asked Questions

Type 1 diabetes clinical trials are research studies that evaluate new investigational approaches to better understand and manage early-stage type 1 diabetes, including how the immune system affects insulin-producing cells.

Autoimmune diabetes clinical trials are generally open to individuals ages 12–35 who have been diagnosed with Stage 3 Type 1 Diabetes within the past 180 days, based on specific eligibility criteria including age, diagnosis timeline, and current health status.

The goal is to evaluate the safety, tolerability, and potential efficacy of an investigational drug that may help preserve insulin-producing cells in people recently diagnosed with Type 1 Diabetes.
Type 1 diabetes clinical trials in Houston, TX are conducted under strict clinical guidelines with continuous medical monitoring to prioritize participant safety and ethical research standards.
Participants will attend scheduled visits, receive three IV infusions of the study drug or placebo, continue their standard insulin therapy, and undergo regular health assessments including safety, immune response, and pancreatic function monitoring over approximately 13 months.
Early-stage research is important because it helps scientists better understand disease progression soon after diagnosis and supports future improvements in diabetes care and management.
Still have questions? Our team is here to support you with your clinical research needs.
Contact Our Team

Join Us

Supporting Innovation
Through Clinical Trials

Join studies designed to advance medical knowledge and support the development of next-generation therapies.
Take the First Step Today